0001209191-22-009249.txt : 20220214
0001209191-22-009249.hdr.sgml : 20220214
20220214162242
ACCESSION NUMBER: 0001209191-22-009249
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220210
FILED AS OF DATE: 20220214
DATE AS OF CHANGE: 20220214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tatsis Ourania
CENTRAL INDEX KEY: 0001789815
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 22632559
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-10
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001789815
Tatsis Ourania
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Reg. & Quality Off.
Common Stock
2022-02-10
4
F
0
1230
237.74
D
58027
D
Common Stock
2022-02-11
4
S
0
100
233.92
D
57927
D
Common Stock
2022-02-11
4
S
0
78
234.93
D
57849
D
Common Stock
2022-02-11
4
S
0
70
235.87
D
57779
D
Common Stock
2022-02-11
4
S
0
42
236.85
D
57737
D
Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $233.92 (range $233.26 to $234.24).
Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $234.93 (range $234.28 to $235.25).
Open market sales reported on this line occurred at a weighted average price of $235.87 (range $235.41 to $236.08).
Open market sales reported on this line occurred at a weighted average price of $236.85 (range $236.84 to $236.87).
/s/ Sabrina Yohai, Attorney-in-Fact
2022-02-14